3 Overrated Stocks We’re Skeptical Of

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.

While momentum can be a leading indicator, it has burned many investors as it doesn’t always correlate with long-term success. All that said, here are three stocks that are likely overheated and some you should look into instead.

Etsy (ETSY)

One-Month Return: +9.3%

Founded by a struggling amateur furniture maker Robert Kalin and his two friends, Etsy (NYSE:ETSY) is one of the world’s largest online marketplaces, focusing on handmade or vintage items.

Why Is ETSY Not Exciting?

1. Active Buyers have declined by 1.7% annually over the last two years, suggesting it may need to revamp its features or user experience to stay competitive
2. Forecasted revenue decline of 2.2% for the upcoming 12 months implies demand will fall off a cliff
3. Incremental sales over the last three years were less profitable as its earnings per share were flat while its revenue grew

Etsy’s stock price of $75.21 implies a valuation ratio of 13.5x forward EV/EBITDA. Dive into our free research report to see why there are better opportunities than ETSY.

Charles River Laboratories (CRL)

One-Month Return: +24.1%

Named after the Massachusetts river where it was founded in 1947, Charles River Laboratories (NYSE:CRL) provides non-clinical drug development services, research models, and manufacturing support to pharmaceutical and biotechnology companies.

Why Are We Wary of CRL?

1. Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion
2. Sales are projected to tank by 4.9% over the next 12 months as its demand continues evaporating
3. Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value

At $231.40 per share, Charles River Laboratories trades at 19.7x forward P/E. Read our free research report to see why you should think twice about including CRL in your portfolio.

State Street (STT)

One-Month Return: +12.2%

Dating back to 1792 when Boston's Long Wharf was the center of global shipping and trade, State Street (NYSE:STT) provides custody, investment management, and other financial services to institutional investors like pension funds, asset managers, and central banks worldwide.

Why Are We Cautious About STT?

1. Annual sales growth of 4.6% over the last five years lagged behind its financials peers as its large revenue base made it difficult to generate incremental demand

State Street is trading at $181.55 per share, or 13.6x forward P/E. Check out our free in-depth research report to learn more about why STT doesn’t pass our bar.

Stocks We Like More

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.